<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="166571">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01985698</url>
  </required_header>
  <id_info>
    <org_study_id>RLOAPR</org_study_id>
    <nct_id>NCT01985698</nct_id>
  </id_info>
  <brief_title>A Trial of Robotic-assisted Versus Laparoscopic Versus Open Abdominoperineal Resection for Treating Low Rectal Cancer</brief_title>
  <acronym>RLOAPR</acronym>
  <official_title>A Multicentre, Prospective, Randomised, Controlled, Unblinded, Parallel-group Trial of Robotic-assisted Versus Laparoscopic Versus Open Abdominoperineal Resection for the Curative Treatment of Low Rectal Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fudan University</source>
  <oversight_info>
    <authority>China: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigators assessed the difference in efficacy and safety among
      robotic-assisted versus laparoscopic versus open abdominoperineal resection for patients
      with low rectal cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be eligible for inclusion if their primary tumors is low rectal cancer.

      Eligible patients will be randomly assigned to robotic-assisted (arm A)versus laparoscopic
      (arm B) versus open abdominoperineal resection (arm C).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>the rate of perioperative complication occurrence</measure>
    <time_frame>6  months following the surgery of rectal cancer</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>perioperative complication</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>disease-free survival time</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>3-year local recurrence, disease-free and overall survival rates and also operative morbidity and mortality, quality of life and cost-effectiveness</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>Robotic-assisted</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with low rectal cancer received robotic-assist resection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laparoscopic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with low rectal cancer received laparoscopic-assist resection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Open Surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients with low rectal cancer received open surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>robotic-assist resection.</intervention_name>
    <description>robotic-assist resection.</description>
    <arm_group_label>Robotic-assisted</arm_group_label>
    <other_name>robotic-assist resection.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoscopic resection</intervention_name>
    <description>Laparoscopic resection</description>
    <arm_group_label>Laparoscopic</arm_group_label>
    <other_name>Laparoscopic resection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open Abdominoperineal Resection</intervention_name>
    <description>Open Abdominoperineal Resection</description>
    <arm_group_label>Open Surgery</arm_group_label>
    <other_name>Open Abdominoperineal Resection</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age between 18-75 years old

          -  Performance status （ECOG）0-1

          -  low rectal carcinoma pathologically

          -  without any pre-operative chemotherapy or radiotherapy

          -  no metastases

          -  suitable for abdominoperineal resection

          -  agreed by patients

        Exclusion Criteria:

          -  age below 18 years old or greater than 75 years old

          -  have not pathological diagnosis of rectal carcinoma

          -  stage cT4NxM0 or cT3N2M0

          -  with any pre-operative chemotherapy or raidotherapy

          -  with metastases

          -  unresectable in operation

          -  not agreed by patients
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jianmin Xu, MD</last_name>
    <phone>+86-13501984869</phone>
    <email>xujmin@aiiyun.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhongshan Hospital, Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jianmin Xu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 9, 2013</lastchanged_date>
  <firstreceived_date>November 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fudan University</investigator_affiliation>
    <investigator_full_name>Xu jianmin</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <keyword>Robotic assist</keyword>
  <keyword>Laparoscopic assist</keyword>
  <keyword>Open Abdominoperineal Resection</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
